Demonstration of Equivalent Effectiveness of a Novel Anti-allergic Nasal Spray and a Marketed Nasal Product as Well as Demonstration of Fast Symptom Reduction in Allergic Patients

Conditions:   Allergic Rhinitis;   Allergic Conjunctivitis;   Hayfever Interventions:   Drug: Rhinocort;   Drug: Budesolv;   Other: Placebo Sponsor:   Marinomed Biotech AG Enrolling by invitation (Source: ClinicalTrials.gov)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2P90hyc